Derivatization Method as a Residual Solvent of Acetic Acid by GC-MS Method in Empagliflozin Drug Substance: Development and Evaluation

The existing study is concerned with isolating unknown impurities from the bulk drug of Empagliflozin. The bulk drug Empagliflozin, Column: Agilent Technologies DB-FFAP 30mx 0.530mm, 1.0-micron, Instrument: PerkinElmer, GC 2014, for GC-MS Column: Agilent Technologies, Elite 5-MS, 30mm X 0.25 mm, 1.0-micron Instrument: Perkin Elmer, Carrier gas: Helium Source Temp.: 230°C, Transfer line: 250°C Inlet Temp.: 180°C, Diluent: Methanol Source energy: 70eV IR and 1HNMR. Column: DB-624,30m x 0.53mm x 3.0 um or equivalent oven Temperature. The injector and detector temperatures were 200°C and 240°C. For a 0.2 ml injection volume and 0.1-minute injection period, the (LOD) Limit of detection and (LOQ) Quantitation were 25 ppm and 76 ppm, respectively. In the Empagliflozin samples, the % recovery for acetic acid varied from 94.10 to 96.31. The devised technique was verified by specificity, linearity, accuracy, quantitation limit, precision, accuracy, and robustness by the principles set out by the International Council on Harmonisation. The IR shows that the Acetic acid impurity was unknown and confirmed. by GC-MS and NMR spectra. An unknown impurity was identified during bulk drug analysis. It was isolated and characterized using various analytical techniques, such as IR, NMR, GC, and GC-MS. Acetic acid, a genotoxic residual solvent, was identified as an unknown impurity and needs to be quantified and validated for routine analytical work. Residual solvents are undesirable compounds (solvents) produced or employed during the production of pharmaceutical formulations, excipients, or drugs, that don't seem to be eliminated by reasonable means in the final product. Method validation was carried out using GC-Column due to better separation in GC-HS mode. The validated method was proven specific, accurate, precise, and sensitive. The advanced and validated process can be implemented to determine and quantify Acetic acid in Empagliflozin bulk drug.

Authors

Institutions

Publication Details

Journal
Research Journal of Pharmacy and Technology
Published
2025-06-12
DOI
https://doi.org/10.52711/0974-360x.2025.00384
Primary Topic
Eicosanoids and Hypertension Pharmacology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Derivatization Method as a Residual Solvent of Acetic Acid by GC-MS Method in Empagliflozin Drug Substance: Development and Evaluation

Sushil Kumar Singh, Manohar V. Lokhande, Amol S Gaikwad
Research Journal of Pharmacy and Technology
Eicosanoids and Hypertension Pharmacology
article

Derivatization Method as a Residual Solvent of Acetic Acid by GC-MS Method in Empagliflozin Drug Substance: Development and Evaluation

Sushil Kumar Singh, Manohar V. Lokhande, Amol S Gaikwad
article en

Abstract

The existing study is concerned with isolating unknown impurities from the bulk drug of Empagliflozin. The bulk drug Empagliflozin, Column: Agilent Technologies DB-FFAP 30mx 0.530mm, 1.0-micron, Instrument: PerkinElmer, GC 2014, for GC-MS Column: Agilent Technologies, Elite 5-MS, 30mm X 0.25 mm, 1.0-micron Instrument: Perkin Elmer, Carrier gas: Helium Source Temp.: 230°C, Transfer line: 250°C Inlet Temp.: 180°C, Diluent: Methanol Source energy: 70eV IR and 1HNMR. Column: DB-624,30m x 0.53mm x 3.0 um or equivalent oven Temperature. The injector and detector temperatures were 200°C and 240°C. For a 0.2 ml injection volume and 0.1-minute injection period, the (LOD) Limit of detection and (LOQ) Quantitation were 25 ppm and 76 ppm, respectively. In the Empagliflozin samples, the % recovery for acetic acid varied from 94.10 to 96.31. The devised technique was verified by specificity, linearity, accuracy, quantitation limit, precision, accuracy, and robustness by the principles set out by the International Council on Harmonisation. The IR shows that the Acetic acid impurity was unknown and confirmed. by GC-MS and NMR spectra. An unknown impurity was identified during bulk drug analysis. It was isolated and characterized using various analytical techniques, such as IR, NMR, GC, and GC-MS. Acetic acid, a genotoxic residual solvent, was identified as an unknown impurity and needs to be quantified and validated for routine analytical work. Residual solvents are undesirable compounds (solvents) produced or employed during the production of pharmaceutical formulations, excipients, or drugs, that don't seem to be eliminated by reasonable means in the final product. Method validation was carried out using GC-Column due to better separation in GC-HS mode. The validated method was proven specific, accurate, precise, and sensitive. The advanced and validated process can be implemented to determine and quantify Acetic acid in Empagliflozin bulk drug.

Research Journal of Pharmacy and Technology
Bombay College of Pharmacy (IN)
Openalex Percentile: Top 81%
Eicosanoids and Hypertension Pharmacology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.